Literature DB >> 35444389

Rapid Desensitization after a Type I Hypersensitivity Reaction to Ceftazidime/ Avibactam.

Col Christopher A Coop1, Maj Joshua R Berg2.   

Abstract

Background: Frequent antibiotic use increases the risk of multidrug-resistant pathogen formation and hypersensitivity to antibiotics, including Type I hypersensitivity reactions. Presentation: We present a case of the first successful induction of tolerance procedure for the antibiotic ceftazidime/ avibactam. The patient developed immediate generalized urticaria and flushing on his first dose of ceftazidime/avibactam. He was able to tolerate a 12-step desensitization procedure that resulted in the clearance of his infection. Conclusions: Drug desensitization procedures are useful for patients with adverse drug reactions in which optimal alternatives are not available. This is the first case report demonstrating a successful rapid induction of tolerance for the antibiotic ceftazidime/avibactam.
Copyright © 2022 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2022        PMID: 35444389      PMCID: PMC9014940          DOI: 10.12788/fp.0220

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  9 in total

Review 1.  Desensitization regimens for drug allergy: state of the art in the 21st century.

Authors:  A Liu; L Fanning; H Chong; J Fernandez; D Sloane; M Sancho-Serra; M Castells
Journal:  Clin Exp Allergy       Date:  2011-08-23       Impact factor: 5.018

Review 2.  Rapid desensitization for hypersensitivity reactions to medications.

Authors:  Mariana Castells
Journal:  Immunol Allergy Clin North Am       Date:  2009-08       Impact factor: 3.479

Review 3.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

4.  A report: the definition and classification of cerebral palsy April 2006.

Authors:  Peter Rosenbaum; Nigel Paneth; Alan Leviton; Murray Goldstein; Martin Bax; Diane Damiano; Bernard Dan; Bo Jacobsson
Journal:  Dev Med Child Neurol Suppl       Date:  2007-02

Review 5.  Respiratory morbidity in children with cerebral palsy: an overview.

Authors:  Lieve Boel; Kurt Pernet; Michel Toussaint; Kris Ides; Glenn Leemans; Jurn Haan; Kim Van Hoorenbeeck; Stijn Verhulst
Journal:  Dev Med Child Neurol       Date:  2018-10-15       Impact factor: 5.449

6.  Analysis of the medical causes of death in cerebral palsy.

Authors:  A Duruflé-Tapin; A Colin; B Nicolas; C Lebreton; F Dauvergne; P Gallien
Journal:  Ann Phys Rehabil Med       Date:  2013-12-02

7.  A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity.

Authors:  Henry J Legere; Ross I Palis; Tito Rodriguez Bouza; Ahmet Z Uluer; Mariana C Castells
Journal:  J Cyst Fibros       Date:  2009-09-08       Impact factor: 5.482

Review 8.  Cerebral palsy and aging.

Authors:  Peterson Haak; Madeleine Lenski; Mary Jo Cooley Hidecker; Min Li; Nigel Paneth
Journal:  Dev Med Child Neurol       Date:  2009-10       Impact factor: 5.449

9.  Risk factors for drug allergy.

Authors:  N F Adkinson
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.